Amneal Pharmaceuticals In... (AMRX)
NASDAQ: AMRX
· Real-Time Price · USD
9.35
-0.04 (-0.43%)
At close: Aug 15, 2025, 2:48 PM
Amneal Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 81.19M | 59.19M | 110.55M | 74.01M | 43.77M | 46.52M | 91.54M | 86.93M | 109.28M | 144.67M | 25.98M | 87.33M | 91.98M | 210.48M | 247.79M | 302.65M | 278.31M | 452.1M |
Short-Term Investments | n/a | n/a | 1.87M | n/a | 3.45M | n/a | n/a | n/a | n/a | 3.31M | 1.82M | 2.17M | 1.69M | 1.59M | 1.17M | 2.11M | 1.3M | n/a |
Long-Term Investments | n/a | 26.39M | 35.92M | 17.94M | n/a | n/a | n/a | n/a | 79.63M | 71.32M | 85.59M | 88.86M | 56.22M | 42.15M | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 44.85M | 19.03M | 24.21M | 18.34M | 77.03M | 73.75M | 55.52M | 89.04M | 13.61M | 86.43M | 103.22M | 108.26M | 8.67M | 63.94M | 20.61M | 145.29M | 19.22M | 19.56M |
Receivables | 809.23M | 800.29M | 808.56M | 786.23M | 769.87M | 668.96M | 645.66M | 690.95M | 722.97M | 545.76M | 741.79M | 660M | 726.61M | 610.1M | 662.58M | 627.95M | 718.27M | 530.6M |
Inventory | 608.97M | 601.43M | 612.45M | 596.36M | 575.62M | 570.65M | 581.38M | 576.47M | 550.56M | 529.04M | 530.74M | 543.86M | 533.03M | 512.24M | 489.39M | 520.25M | 523.38M | 497.01M |
Other Current Assets | 85.3M | 9.02M | 7.87M | 4.34M | 39.36M | 40.19M | 7.57M | 48.89M | 5.3M | 44.35M | 64.37M | 112.82M | 192.46M | 77.86M | 74.11M | 75.8M | 71.1M | 4.82M |
Total Current Assets | 1.58B | 1.51B | 1.59B | 1.51B | 1.49B | 1.38B | 1.38B | 1.46B | 1.42B | 1.31B | 1.41B | 1.42B | 1.55B | 1.39B | 1.52B | 1.57B | 1.56B | 1.56B |
Property-Plant & Equipment | 546.29M | 522.75M | 523.69M | 532.9M | 528.94M | 544.78M | 550.14M | 560.8M | 571.27M | 578.38M | 589.36M | 587.44M | 602.77M | 622.64M | 639M | 459.65M | 597.95M | 595.14M |
Goodwill & Intangibles | 1.25B | 1.29B | 1.33B | 1.38B | 1.42B | 1.46B | 1.49B | 1.58B | 1.61B | 1.65B | 1.69B | 1.76B | 1.81B | 1.81B | 1.76B | 1.8B | 1.84B | 1.79B |
Total Long-Term Assets | 1.84B | 1.85B | 1.91B | 1.95B | 2.02B | 2.08B | 2.09B | 2.23B | 2.28B | 2.32B | 2.39B | 2.45B | 2.49B | 2.5B | 2.42B | 2.4B | 2.46B | 2.4B |
Total Assets | 3.42B | 3.37B | 3.5B | 3.46B | 3.51B | 3.46B | 3.47B | 3.69B | 3.7B | 3.63B | 3.8B | 3.87B | 4.04B | 3.89B | 3.94B | 3.97B | 4.02B | 3.96B |
Account Payables | 666.82M | 192.53M | 258.69M | 235M | 201.78M | 176.97M | 145.53M | 177.4M | 139.53M | 136.92M | 166.84M | 533.44M | 563.83M | 541.8M | 132.87M | 591.21M | 597.93M | 581.42M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | 400.27M | 398.41M | 3.5M | n/a | n/a | n/a | n/a | 24.9M | n/a | -452.26M | n/a | n/a | n/a |
Short-Term Debt | 335.41M | 321.79M | 324.21M | 364.69M | 435.52M | 212.66M | 213.13M | 106.53M | 150.41M | 129.97M | 89.96M | 89.94M | 114.92M | 30.52M | 30.61M | 30.47M | 30.46M | 29.82M |
Other Current Liabilities | 104.91M | 85.1M | 136.1M | 198.08M | 192.56M | 74.94M | 227.43M | 220.01M | 240.77M | 241.76M | 263.11M | 177.48M | 277.55M | 13.39M | 277.77M | 29.97M | 30.23M | 12M |
Total Current Liabilities | 1.11B | 1.08B | 1.13B | 1.1B | 1.11B | 834.39M | 846.6M | 760.6M | 777.35M | 703.71M | 752.8M | 818M | 993.06M | 602.04M | 677.24M | 667.34M | 672.86M | 636.78M |
Long-Term Debt | 2.15B | 2.15B | 2.16B | 2.17B | 2.18B | 2.42B | 2.43B | 2.58B | 2.59B | 2.6B | 2.63B | 2.65B | 2.66B | 2.71B | 2.72B | 2.73B | 2.76B | 2.77B |
Other Long-Term Liabilities | 115.9M | 106.86M | 163.33M | 135.81M | 126.14M | 121.45M | 83.06M | 52.92M | 48.41M | 52.66M | 97.12M | 88.55M | 89.87M | 59.66M | 65.43M | 85.62M | 86.08M | 78.93M |
Total Long-Term Liabilities | 2.36B | 2.35B | 2.42B | 2.4B | 2.4B | 2.64B | 2.61B | 2.74B | 2.74B | 2.76B | 2.84B | 3.03B | 2.86B | 2.88B | 2.9B | 2.92B | 2.96B | 2.96B |
Total Liabilities | 3.47B | 3.42B | 3.55B | 3.49B | 3.51B | 3.47B | 3.45B | 3.5B | 3.52B | 3.46B | 3.59B | 3.85B | 3.85B | 3.48B | 3.57B | 3.59B | 3.63B | 3.59B |
Total Debt | 2.58B | 2.58B | 2.59B | 2.64B | 2.73B | 2.75B | 2.75B | 2.8B | 2.86B | 2.85B | 2.85B | 2.86B | 2.9B | 2.87B | 2.88B | 2.73B | 2.92B | 2.92B |
Common Stock | n/a | 3.13M | 3.1M | 3.1M | 3.1M | 3.09M | 3.07M | 3.06M | 3.06M | 3.05M | 3.04M | 3.04M | 3.03M | 3.03M | 3.01M | 3.01M | 3.01M | 3.01M |
Retained Earnings | n/a | -594.87M | -607.06M | -575.98M | -575.83M | -581.82M | -490.18M | -391.53M | -401.21M | -413.13M | -406.18M | -401.85M | -399.16M | -278.35M | -276.2M | -269.82M | -265.58M | -280.12M |
Comprehensive Income | n/a | -85.74M | -65.51M | -73.78M | -30.44M | -23.71M | -32.35M | 3.87M | 8.08M | 3.76M | 9.94M | 12.54M | 868K | -349K | -24.83M | -33.23M | -33.98M | -34.36M |
Shareholders Equity | -112.53M | -131.67M | -109.27M | -93.43M | -57.47M | -63.72M | 19.78M | 330.86M | 318.17M | 134.67M | 183.98M | 297.47M | 280.33M | 391.13M | 366.97M | 383.17M | 346.11M | 323.01M |
Total Investments | n/a | 26.39M | 37.79M | 17.94M | 55.91M | n/a | n/a | n/a | 82.99M | 74.62M | 87.41M | 91.03M | 57.91M | 43.75M | 1.17M | 2.11M | 1.3M | n/a |